Recently, BH3 mimetics developed to functionally mimic pro-apoptotic BCL-2 proteins were shown to neutralize anti-apoptotic proteins, enabling efficient apoptosis in cancer cells [22]. The gene discussed is BCL2; the disease is cancer.